________________________________________________________
____Explicit____
189..196
1,1
#### Text ####
earlier
##############
#### Features ####
Wr, Comm, Null, Null
earlier, Temporal.Asynchronous.Succession
____Arg1____
9..171
0
#### Text ####
Ciba-Geigy Ltd. and Chiron Corp. said they extended their offer for Connaught BioSciences Inc., valued at 866 million Canadian dollars (US$736 million) to Oct. 27
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
175..188;197..319
1,0;1,2;1,3
#### Text ####
The companies said they didn't want to raise their offer to match a rival bid by Institut Merieux S.A. of C$37 a share, or C$942 million
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
321..324
2,0
#### Text ####
But
##############
#### Features ####
Wr, Comm, Null, Null
but, Comparison.Contrast
____Arg1____
202..319
1,2,1
#### Text ####
they didn't want to raise their offer to match a rival bid by Institut Merieux S.A. of C$37 a share, or C$942 million
##############
#### Features ####
Ot, Comm, Null, Null
175..201
1,0;1,1;1,2,0;1,3
#### Text ####
The companies earlier said
##############
____Arg2____
335..420
2,2,1
#### Text ####
the C$30-a-share bid, which was due to expire Monday, may still be extended or varied
##############
#### Features ####
Ot, Comm, Null, Null
325..334
2,1;2,2,0;2,3
#### Text ####
they said
##############
________________________________________________________
________________________________________________________
____Explicit____
393..398
2,2,1,1,1,1
#### Text ####
still
##############
#### Features ####
Ot, Comm, Null, Null
325..334
2,1;2,2,0;2,3
#### Text ####
they said
##############
still, Comparison.Contrast.Opposition
____Arg1____
357..387
2,2,1,1,0,2
#### Text ####
which was due to expire Monday
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
335..355;389..392;399..420
2,2,1,0;2,2,1,1,0,0;2,2,1,1,0,1;2,2,1,1,0,3;2,2,1,1,1,0;2,2,1,1,1,2
#### Text ####
the C$30-a-share bid may be extended or varied
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
532
4
#### Features ####
Wr, Comm, Null, Null
while, Comparison.Contrast.Juxtaposition
____Arg1____
424..530
3
#### Text ####
Merieux, a vaccine manufacturer based in Lyon, France, is 51%-held by French state-owned Rhone-Poulenc S.A
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
532..604
4
#### Text ####
Ciba-Geigy is a major pharmaceutical concern based in Basel, Switzerland
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
606
5
#### Features ####
Wr, Comm, Null, Null
and, Expansion.Conjunction
____Arg1____
532..604
4
#### Text ####
Ciba-Geigy is a major pharmaceutical concern based in Basel, Switzerland
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
606..675
5
#### Text ####
Chiron, another pharmaceutical concern, is based in Emeryville, Calif
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
677
6
#### Features ####
Wr, Comm, Null, Null
and, Expansion.Conjunction
____Arg1____
532..675
4;5
#### Text ####
Ciba-Geigy is a major pharmaceutical concern based in Basel, Switzerland.
Chiron, another pharmaceutical concern, is based in Emeryville, Calif
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
677..748
6
#### Text ####
Connaught is a biotechnology research and vaccine manufacturing concern
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
976
8
#### Features ####
Wr, Comm, Null, Null
consequently, Contingency.Cause.Result
____Arg1____
752..853
7,0;7,1,0;7,1,1,0;7,1,1,1,0;7,1,1,1,1,0;7,1,1,1,1,1,0;7,1,1,1,1,1,1,0;7,1,1,1,1,1,1,1;7,2
#### Text ####
Institut Merieux's bid for Toronto-based Connaught has run into problems with the Canadian government
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
976..1077
8
#### Text ####
Merieux officials are expected to meet with federal officials in Ottawa today to discuss the decision
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
